This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Concrete, medicine and real estate deals filed with competition agency in Brazil

( June 1, 2016, 14:02 GMT | Official Statement) -- MLex Summary: The Brazilian competition watchdog has disclosed three deals awaiting fast-track reviews: concrete compay Supermix Concreto's plan to buy a concrete plant in Pernambuco state from rival Lafarge Brasil; a plan by pharmaceutical company Takeda Pharma to produce two medicines, Protovit Plus Gotas and Redoxon Gotas, for Bayer, which will sell them; and a plan by full-service real estate developer LDI Desenvolvimento Imobiliário to acquire PDG Realty S.A. Empreendimentos e Participações' stake in REP Real Estate Partners–Desenvolvimento Imobiliário. After the transaction, LDI will hold a majority stake in REP.OJ statements follow in Portuguese....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login